Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,984,690
Closed -$96.4M 97
2020
Q4
$96.4M Buy
1,984,690
+241,642
+14% +$11.9M 1.17% 24
2020
Q3
$87.4M Buy
1,743,048
+517,548
+42% +$26.6M 1.61% 18
2020
Q2
$62.6M Buy
+1,225,500
New +$59.6M 1.16% 26

Other funds holding SNY

Redmile Group's SNY Position: Q1 2021 in Review

Redmile Group sold out of Sanofi (SNY) in Q1 2021, closing a stake of 1,984,690 shares — an estimated $96.4M sold.

Redmile Group first reported a position in SNY in Q2 2020 and held it in 3 quarters. The position peaked at $96.4M in Q4 2020. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Redmile Group reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
  • Redmile Group sold 1,984,690 Sanofi shares in Q1 2021, an estimated $96.4M.
  • Redmile Group first reported a position in Sanofi in Q2 2020 and held it in 3 quarters.
  • Redmile Group's Sanofi position peaked at $96.4M in Q4 2020.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Redmile Group's 13F filing for Q1 2021, filed 17 May 2021.